First Medical Patent Issued for the Oculenz(TM) Augmented Reality Glasses
Ocutrx(TM) AR Glasses Garners First Medical Patent for Restoring Functional Sight to Patients with Visual Field Deficits
IRVINE, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California based Augmented Reality (AR) Glasses developer today announced that the company's core AR medical application technology has been issued its first patent by the United States Patent and Trademark Office (USPTO). The company's Augmented Reality headset, called Oculenz(TM) boasts the widest field-of-vision in the industry, with a 110-degree high-resolution heads-up display, in a wirelessly connected, untethered, micro-weight headset. The patent also teaches how the Oculenz ARwear(TM) can work in conjunction with smart contact lenses as the display and eye-tracking.
"This first patent award validates our core technology for using our AR platform innovations for medical applications," stated Michael H. Freeman, CEO/CTO and Founder of Ocutrx. "This is a real milestone for creating value for Ocutrx's patent portfolio and an incredible step forward in securing patent rights around the world," Freeman said. "We immediately filed a Continuation Patent to focus on the previously filed specification elements incorporating eye-tracking with an AR head mounted display for the larger AR market."
The company plans to also market their Oculenz to other sectors including gaming, commercial, industrial, HAZMAT, e-commerce, aerospace, drones and defense. "While many AR companies built a platform first, and are now looking to find a market," said Scott Evans, M.B.A., Ocutrx COO, "we strategically designed our first ARwear for the medical industry, where there are many highly-motivated buyers, then we intent to expand into the AR market-at-large."
Ocutrx was founded in 2015 by Michael H. Freeman, an Emmy Award-winning designer of streaming mobile video technology which became the basis for the IEEE 802.11(n) MIMO standard. Freeman created the first streaming smart-phone video product which was licensed by virtually all of the cell companies which existed in the 1990's. The streaming video technology and patents were later sold to Samsung Electronics.
"The Oculenz is the first ground-breaking technology to offer a solution for advanced central visual defects in patients with retinal disease," said Dr. Thomas Finley, M.D. a Vitreoretinal surgeon and member of the Ocutrx International Medical Advisory Board (IMAB). "This innovative AR device brings a new hope to regain functional vision previously considered impossible. The impact on the individual's quality of life and retained or regained ability to productively function at home and in the workplace will be immeasurable."
The USPTO determined that Ocutrx's first patent application was allowable covering a diagnostic phase where the patients can wear the Oculenz to map their own retinal defects, alone or with the help of their physicians, and a second corresponding display phase where the video is buffered according to the retinal map and displayed over the patient's real-world vision. The Oculenz's buffered display shows all the real-world video image, but none is shown on the exact area of the patient's eye defect. Instead, it is directed to the patient's existing good areas of the macula or near adjacent peripheral retina.
"The Oculenz technology works somewhat like how we all have a natural blind spot in our vision that we do not realize on a day to day basis," said Dr. Lars Freisberg, M.D., an international Retinal Specialist surgeon, licensed in the U.S., Norway and Germany, and member of the Ocutrx IMAB. "However, you never really see this hole," explained Dr. Freisberg, "because the brain fills it in with other gathered visual information."
"With the Oculenz the idea is that the patient senses the entire image and learns to disregard the defect area through 'neural adaptation' due to the 'plasticity of the brain,'" said Dr. R. Wade Crow, M.D., Neural Ophthalmologist and Assistant Professor of Neuro-Ophthalmology at the University of California-Irvine and member of the Ocutrx IMAB. "Working with visual input, the brain can train itself to not see redundant or unnecessary things."
About Ocutr x
With corporate headquarters in the OC at Irvine, California, and a research and R&D lab in the Midwest, located in Oklahoma, Ocutrx is a new breed of AR manufacturing company focusing on the lightest weight headset with the largest field-of-vision in the market. At a time when worldwide applications for easy-to-wear and easy-to-use AR solutions are being touted as the "next big thing after the smartphone" Ocutrx is creating impactful, revolutionary "AR glasses for the masses"(TM).
To learn more about Ocutrx, please visit the company website at www.ocutrxarwear.com.
Ocutrx Vision Technologies, LLC
Photos accompanying this announcement are available at
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ocutrx Vision Technologies, LLC via Globenewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
CTG Promotes Three Long-time Business Leaders in Europe15.2.2019 15:00:00 | Pressemelding
Bob Daelman, Guido Helsloot and Rénald Wauthier named Vice Presidents BUFFALO, N.Y., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CTG (NASDAQ: CTG), a leading provider of information technology (IT) solutions and services in North America and Western Europe, announced today that three of the Company’s high-performing managers in its European business, Bob Daelman, Guido Helsloot and Rénald Wauthier, have each been named vice president. “Bob Daelman and Rénald Wauthier have proven track records of significantly expanding their respective businesses in Europe. Guido Helsloot has been key enabler in effecting two acquisitions in the past six years that expanded our operations and was again instrumental in driving our recent Tech-IT acquisition that will give CTG broader end-to-end capabilities to better-serve our clients. Together, this team has greatly contributed to our success in Europe, where CTG has recorded eight consecutive years of revenue growth,” commented Filip Gydé, current Executive Vic
Jazwares Announces Partnership with Kellytoy for Russ Berrie™ Worldwide15.2.2019 01:00:00 | Pressemelding
Sunrise, FL, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Jazwares LLC, a global leader in toys and licensing, announced today that its affiliate Zag Toys, LLC (“Zag Toys”) formed a strategic partnership for their wholly owned brand Russ Berrie™, with Kellytoy, an influential manufacturer and distributor of plush toys and pet products. This relationship will carry on the 50+ year legacy of the Russ Berrie™ brand, positioning it globally as the premier plush brand on retail shelves in Fall 2019. Kellytoy will market the Russ Berrie™ brand through its global distribution channels, which include almost every market segment. “Working together with Kellytoy will maximize the Russ Berrie™ legacy,” says Judd Zebersky, Jazwares CEO and President. “By leveraging Russ Berrie™ and its reputation for quality and commitment to “Make Someone Happy™” with Kellytoy’s global footprint we’ll secure placement in retailers all around the world, putting Russ Berrie™ at the forefront of today’s plush presence at retai
PROFEPA report confirms no contamination of soil from overflow of contingency pond at the San Jose Mine, Mexico in October 201814.2.2019 19:46:00 | Pressemelding
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to report that the Federal Attorney's Office for Environmental Protection (PROFEPA) has completed its investigation into the overflow of the contingency pond at the dry stack tailings facility at the San Jose Mine on October 8, 2018, which was caused by heavy seasonal rains (refer to Fortuna news release dated October 11, 2018). PROFEPA’s final report confirms that the overflow did not contaminate soil, and therefore no remediation is required. The Company awaits a final report from the Mexican National Water Commission (CONAGUA). The Company reiterates its commitment to safeguarding the wellbeing of the environment, local communities and our work force. About Fortuna Silver Mines Inc. Fortuna is a growth oriented, precious metals producer focused on mining opportunities in Latin America. Our primary assets are the Caylloma silver Mine in southern Peru, the San Jos
Cloudian HyperStore Named 2018 Product of the Year in Software-defined and Cloud Storage by Storage Magazine14.2.2019 19:10:00 | Pressemelding
Also Wins Best Hybrid Cloud Solution in 2018-2019 Cloud Awards, Further Reinforcing Company’s Object Storage Leadership SAN MATEO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Cloudian today announced two top industry awards for its HyperStore object storage platform. The awards are the latest honors for the company’s limitlessly scalable, highly cost-effective solution, which provides the industry’s best S3 compatibility and seamless data management across on-premises and public cloud environments. 2018 Software-defined and Cloud Storage Product of the Year TechTarget’s Storage magazine and SearchStorage.com named HyperStore 7 as the Gold winner in the Software-defined and Cloud Storage category of the 2018 Products of the Year Awards. The judging panel of analysts, consultants, users and TechTarget writers were “particularly impressed with [HyperStore’s] functionality.” In addition, the solution received high marks for innovation, value and ease of integration, use and manageability, en
Hot Silicon Valley Tech Firm Grows in Krakow14.2.2019 16:28:00 | Pressemelding
SignalFx Opens Research and Development and Support Office; Hires Industry Veteran Martin Burlinski, Head of Engineering, EMEA SAN MATEO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- SignalFx, the leader in real-time cloud monitoring for infrastructure, microservices, and applications, is announcing the opening of a new Research, Development and Support Office in Krakow, Poland and the addition of Martin Burlinski, Head of Engineering, EMEA. The new Krakow facility will enable SignalFx to accelerate product development and provide broader global support for its customers. “We were naturally attracted to Krakow not only because of its strong existing talent pool of world-class engineers but also its proximity to recent graduates from the city’s many universities,” said Leonid Igolnik, EVP Engineering for SignalFx. “We have an immediate need for engineers to become a core part of our company working side-by-side with our Silicon Valley and Research Triangle Park teams. With a global client
HL7 and SNOMED International Announce Agreement for Free Set of Terms for Use with International Patient Summary14.2.2019 15:00:00 | Pressemelding
Orlando, Fl., Feb. 14, 2019 (GLOBE NEWSWIRE) -- SNOMED International and Health Level Seven International (HL7) announce today the formalization of a license agreement in which a relevant ‘Free for Use’ Set of SNOMED CT coded concepts will be used within the HL7 International Patient Summary (IPS). Health Level Seven International (HL7) is a not-for-profit, ANSI-accredited standards developing organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. SNOMED International is a not-for-profit, member-owned and driven international organization charged with maintaining and releasing the SNOMED CT clinical terminology product; the world’s most comprehensive clinical terminology. Presently comprised of 38 Member countries globally, SNOMED International supports the role that structured